A Phase 3 Triple Blind Parallel Group Long Term Placebo Controlled Multicenter Study to Examine the Effect on Glucose Control hbAlc of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with a Sulfonylurea Alone

  • Reynolds, L (PI)
  • Anderson, James (CoI)

Grants and Contracts Details

Effective start/end date4/10/023/31/03